Skip to main content

Table 4 Logistic regression of probability of hospitalization of cystic fibrosis patients, N = 804.

From: Adherence with tobramycin inhaled solution and health care utilization

  AOR* 95% CI
Overall adherence with TIS   
   Low (reference) 1.0  
   Medium 0.94 0.62-1.41
   High 0.40 0.19-0.84
Age (in years)   
   <6 (reference) 1.0  
   6-10 1.76 0.89-3.47
   11-17 1.52 0.86-2.69
   18-25 1.48 0.80-2.73
   ≥26 0.73 0.38-1.39
Gender   
   Male (reference) 1.0  
   Female 1.04 0.74-1.44
Comorbidity score   
   ≤Average (reference) 1.0  
   >Average 7.53** 5.20-10.90
Selected comorbidity   
   Pseudomonas aeruginosa 3.0** 2.13-4.32
   Failure to thrive/growth failure 2.8** 1.09-7.14
  1. *Adjusted for variables in the table and health plan type and geographic residence; **p < 0.05
  2. AOR = adjusted odds ratio; CI = confidence interval; TIS = tobramycin